Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors

Accomplished finance and enterprise executive with over 20 years of global leadership in multinational and Fortune 500 companiesBRISBANE, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. NASDAQ:TPST (“Tempest”), a clinical-stage biotechnology company developing in vivo CAR-T th…